株探米国株
日本語 英語
エドガーで原本を確認する
False000142322100014232212026-06-042026-06-04iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  June 4, 2026

_______________________________

Quanex Building Products Corporation

(Exact name of registrant as specified in its charter)

_______________________________

Delaware 001-33913 26-1561397
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

945 Bunker Hill Road, Suite 900

Houston, Texas 77024

(Address of Principal Executive Offices) (Zip Code)

(713) 961-4600

(Registrant's telephone number, including area code)

 

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share NX New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
 
Item 2.02. Results of Operations and Financial Condition.

 

On June 4, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.
     
99.1   Press Release dated June 4, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Quanex Building Products Corporation
     
   
Date: June 4, 2026 By:  /s/ SCOTT ZUEHLKE        
    Scott Zuehlke
    SVP, CFO and Treasurer
   

 

EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

Quanex Building Products Announces Second Quarter 2026 Results

Net Sales Growth of ~2% Year-Over-Year
Volumes Tracking Normal Seasonality Patterns
Price vs Cost Imbalance Being Addressed
Executing on Working Capital Management

HOUSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended April 30, 2026.  

The Company reported the following selected financial results:

  Three Months Ended April 30,   Six Months Ended April 30,
($ in millions, except per share data)   2026       2025       2026       2025  
Net Sales $ 462.4     $ 452.5     $ 871.5     $ 852.5  
Gross Margin $ 117.8     $ 131.4     $ 216.3     $ 223.7  
Gross Margin %   25.5 %     29.0 %     24.8 %     26.2 %
Net Income (Loss) $ 3.4     $ 20.5     $ (0.7 )   $ 5.6  
Diluted EPS $ 0.07     $ 0.44     $ (0.02 )   $ 0.12  
               
Adjusted Net Income $ 11.3     $ 29.1     $ 11.0     $ 38.1  
Adjusted Diluted EPS $ 0.25     $ 0.63     $ 0.24     $ 0.81  
Adjusted EBITDA $ 44.2     $ 63.1     $ 71.6     $ 101.7  
Adjusted EBITDA Margin %   9.6 %     14.0 %     8.2 %     11.9 %
               
Cash Provided By (Used For) Operating Activities $ 18.9     $ 28.5     $ (1.3 )   $ 16.0  
Free Cash Flow $ 7.9     $ 13.6     $ (23.6 )   $ (10.6 )

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, commented, “Despite the headwinds our industry is facing, demand for the products we manufacture was as expected during the second quarter of 2026. Rapid inflationary pressures related to macroeconomic concerns and the ongoing conflict in the Middle East led to an unfavorable price versus cost dynamic, which pressured our margins. As previously disclosed, we utilize surcharges to respond to rapid increases in costs and we have index pricing mechanisms in place in North America to handle fluctuations in major raw material costs, but when costs increase quickly there is a timing lag and margins are negatively impacted. We are addressing the current price versus cost imbalance to minimize further negative impact and expect to recover some of the shortfall to date during the second half of this year, assuming volumes continue to track the normal seasonality of our business, and the rate of inflationary pressure subsides.

“We expected to be a net borrower during the second quarter due to the seasonality of our business, coupled with the longer cash conversion cycle of the legacy Tyman business, but continued execution on managing working capital, coupled with the seasonal uptick in volumes, enabled us to avoid being a net borrower for the quarter. We intend to prioritize debt repayment and opportunistic share repurchases as we generate cash in the second half. In addition, we will continue to focus on the things we can control, which includes identifying operational efficiencies and commercial synergies that we believe will benefit us when consumer confidence improves and demand rebounds.”

Second Quarter 2026 Results Summary   

Quanex reported net sales of $462.4 million during the three months ended April 30, 2026, which represents an increase of 2.2% compared to $452.5 million for the same period in 2025, mainly due to favorable impacts from pricing, including tariff-related price recoveries, and foreign exchange translation. The Hardware Solutions and Extruded Solutions segments each reported modest increases in net sales for the second quarter of 2026, as lower volumes were offset by favorable impacts from pricing, including tariff-related recoveries and foreign exchange translation. Quanex reported an increase of 6.6% in net sales for the second quarter of 2026 in its Custom Solutions segment, largely due to increased volume and improved pricing. (See Sales Analysis table for additional information)

On a consolidated basis, the decrease in adjusted earnings for the second quarter of 2026 compared to the second quarter of 2025 was mainly due to reduced operating leverage from lower volumes related to ongoing macroeconomic uncertainty combined with weak consumer confidence, tariff-related costs and inflationary pressures. More specifically, due to the ongoing war in the Middle East, the Company realized a significant increase in transportation and raw material costs during the quarter.     

Balance Sheet & Liquidity Update

As of April 30, 2026, the Company had total debt of $715.0 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA was 3.1x. As of April 30, 2026, Quanex reported a LTM Net Loss of $257.2 million, mainly due to the non-cash goodwill impairment charge recorded in the third quarter of 2025, and LTM Adjusted EBITDA of $212.8 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company’s liquidity was $328.6 million as of April 30, 2026, consisting of $63.7 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Conference Call and Webcast Information

The Company has scheduled a conference call for Friday, June 5, 2026, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register-conf.media-server.com/register/BIcb9c8924a43d483f9a1238134ae8964f

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Contact:

Scott Zuehlke
SVP, Chief Financial Officer & Treasurer
713-877-5327
scott.zuehlke@quanex.com

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflect operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  These measures allow management and investors to evaluate operational performance and trends without the impact of certain non-cash charges, acquisition-related costs, and other items that may vary significantly from period to period and may not be reflective of Quanex’s core operating results. The presented non-GAAP measures may not be the same as those used by other companies. The Company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.   Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” “anticipate,” “intend,” “plan,” “project,” “seek,” “would,” “may,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, expectations regarding the recovery of price versus cost imbalances, anticipated debt repayment and share repurchase activity, expected operational efficiencies and synergies and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from those expressed or implied in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

       
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
       
  Three Months Ended April 30,   Six Months Ended April 30,
    2026       2025       2026       2025  
               
Net sales $ 462,367     $ 452,478     $ 871,456     $ 852,522  
Cost of sales   344,575       321,096       655,137       628,824  
Selling, general and administrative   74,432       70,333       145,858       136,983  
Restructuring charges   -       936       -       8,840  
Depreciation and amortization   24,650       19,192       48,899       43,932  
Operating income   18,710       40,921       21,562       33,943  
Interest expense   (12,042 )     (13,940 )     (24,409 )     (28,126 )
Other, net   448       (159 )     6,065       1,070  
Income before income taxes   7,116       26,822       3,218       6,887  
Income tax expense   (3,766 )     (6,307 )     (3,939 )     (1,257 )
Net income (loss) $ 3,350     $ 20,515     $ (721 )   $ 5,630  
               
Earnings (loss) per common share, basic $ 0.07     $ 0.44     $ (0.02 )   $ 0.12  
Earnings (loss) per common share, diluted $ 0.07     $ 0.44     $ (0.02 )   $ 0.12  
               
Weighted average common shares outstanding:              
Basic   45,483       46,483       45,469       46,753  
Diluted   45,658       46,563       45,469       46,868  
               
Cash dividends per share $ 0.08     $ 0.08     $ 0.16     $ 0.16  
                               


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
       
  April 30, 2026   October 31, 2025
ASSETS      
Current assets:      
Cash and cash equivalents $ 63,671     $ 76,018  
Restricted Cash   2,313       2,100  
Accounts receivable, net   211,088       205,384  
Inventories   278,047       254,122  
Income taxes receivable   6,121       -  
Prepaid assets   39,542       32,387  
Other current assets   3,651       3,764  
Total current assets   604,433       573,775  
Property, plant and equipment, net   399,190       411,591  
Operating lease right-of-use assets   176,809       154,866  
Deferred tax assets   250       2,706  
Goodwill   274,750       271,346  
Intangible assets, net   533,395       549,137  
Other assets   4,348       4,812  
Total assets $ 1,993,175     $ 1,968,233  
       
LIABILITIES AND STOCKHOLDERS' EQUITY      
Current liabilities:      
Accounts payable $ 127,709     $ 131,307  
Accrued liabilities   85,666       95,155  
Income taxes payable   6,289       12,076  
Current maturities of long-term debt   26,545       27,561  
Current operating lease liabilities   18,911       15,446  
Total current liabilities   265,120       281,545  
Long-term debt   678,932       665,268  
Noncurrent operating lease liabilities   164,958       145,459  
Deferred income taxes   141,104       135,993  
Other liabilities   15,703       13,789  
Total liabilities   1,265,817       1,242,054  
Stockholders’ equity:      
Common stock   512       512  
Additional paid-in-capital   696,391       700,029  
Retained earnings   156,641       164,710  
Accumulated other comprehensive loss   (27,897 )     (35,439 )
Treasury stock at cost   (98,289 )     (103,633 )
Total stockholders’ equity   727,358       726,179  
Total liabilities and stockholders' equity $ 1,993,175     $ 1,968,233  
               


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
   
  Six Months Ended April 30,
    2026       2025  
Operating activities:      
Net (loss) income $ (721 )   $ 5,630  
Adjustments to reconcile net loss to cash used for operating activities:      
Depreciation and amortization   48,899       43,932  
Stock-based compensation   2,402       1,825  
Deferred income tax   918       1,250  
Other, net   3,800       7,243  
Changes in assets and liabilities:      
(Increase) decrease in accounts receivable   (4,479 )     5,322  
Increase in inventory   (21,719 )     (1,333 )
Increase in other current assets   (6,200 )     (7,828 )
Decrease in accounts payable   (2,459 )     (14,771 )
Decrease in accrued liabilities   (10,411 )     (14,048 )
Change in income taxes   (12,005 )     (5,471 )
Other, net   689       (5,764 )
Cash (used for) provided by operating activities   (1,286 )     15,987  
Investing activities:      
Capital expenditures   (22,322 )     (26,544 )
Proceeds from disposition of capital assets   29       376  
Cash used for investing activities   (22,293 )     (26,168 )
Financing activities:      
Borrowings under credit facilities   119,000       125,000  
Repayments of credit facility borrowings   (99,500 )     (117,500 )
Repayments of other long-term debt   (1,762 )     (1,888 )
Common stock dividends paid   (7,277 )     (7,552 )
Purchase of treasury stock   -       (27,194 )
Other, net   (696 )     (1,186 )
Cash provided by (used for) financing activities   9,765       (30,320 )
Effect of exchange rate changes on cash and cash equivalents   1,680       2,303  
Decrease in cash, cash equivalents and restricted cash   (12,134 )     (38,198 )
Cash, cash equivalents and restricted cash at beginning of period   78,118       102,995  
Cash, cash equivalents and restricted cash at end of period $ 65,984     $ 64,797  
               
QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)
               

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

  Three Months Ended April 30,   Six Months Ended April 30,
  2026     2025     2026   2025
Cash (used for) provided by operating activities 18,922     $ 28,497     (1,286 )   15,987  
Capital expenditures (11,028 )     (14,920 )   (22,322 )   (26,544 )
Free Cash Flow 7,894     $ 13,577     (23,608 )   (10,557 )
                         

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

  As of April 30,
    2026       2025  
Term loan facility $ 456,250     $ 481,205  
Revolving credit facility   204,500       242,500  
Finance lease obligations (1)   54,294       61,272  
Total debt (2)   715,044       784,977  
Less: Cash and cash equivalents   63,671       62,626  
Net Debt   651,373       722,351  
           

(1) Includes $48.6 million and $57.4 million in real estate lease liabilities considered finance leases under U.S. GAAP as of April 30, 2026 and 2025, respectively.
(2) Excludes outstanding letters of credit.

                     
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)
                     
Reconciliation of Last Twelve Months Adjusted EBITDA   Three Months Ended
April 30, 2026
  Three Months Ended
January 31, 2026
  Three Months Ended
October 31, 2025
  Three Months Ended
July 31, 2025
  Total
    Reconciliation   Reconciliation   Reconciliation   Reconciliation   Reconciliation
Net income (loss) as reported   $ 3,350     $ (4,071 )   $ 19,571     $ (276,007 )   $ (257,157 )
Income tax expense (benefit)     3,766       173       15,147       (8,191 )     10,895  
Other, net     (448 )     (5,617 )     (5,246 )     (855 )     (12,166 )
Interest expense     12,042       12,367       13,468       14,218       52,095  
Depreciation and amortization     24,650       24,249       25,630       33,882       108,411  
Asset impairment charges     -       -       -       302,284       302,284  
EBITDA     43,360       27,101       68,570       65,331       204,362  
Cost of sales (1)     121       407       308       148       984  
Selling, general and administrative (1),(2)     688       (126 )     2,056       3,449       6,067  
Restructuring (credit) charges (3)     -       -       (16 )     1,367       1,351  
Adjusted EBITDA   $ 44,169     $ 27,382     $ 70,918     $ 70,295     $ 212,764  
                     

(1) Expense related to plant closure/relocation.
(2) Transaction, advisory fees, reorganization costs and product recall expenses.
(3) Restructuring (credit) charges related to severance.

               
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
               
Reconciliation of Adjusted Net Income and Adjusted EPS Three Months Ended
April 30, 2026
  Three Months Ended
April 30, 2025
  Six Months Ended
April 30, 2026
  Six Months Ended
April 30, 2025
    Net
Income
  Diluted
EPS
  Net
Income
  Diluted
EPS
  Net
Income
  Diluted
EPS
  Net
Income
  Diluted
EPS
Net income (loss) as reported   $ 3,350     $ 0.07     $ 20,515     $ 0.44     $ (721 )   $ (0.02 )   $ 5,630     $ 0.12  
Net income reconciling items from below     7,913     $ 0.18       8,597     $ 0.19       11,714     $ 0.26       32,444     $ 0.69  
Adjusted net income and adjusted EPS   $ 11,263     $ 0.25     $ 29,112     $ 0.63     $ 10,993     $ 0.24     $ 38,074     $ 0.81  
                                 
Reconciliation of Adjusted EBITDA   Three Months Ended
April 30, 2026
  Three Months Ended
April 30, 2025
  Six Months Ended
April 30, 2026
  Six Months Ended
April 30, 2025
    Reconciliation       Reconciliation       Reconciliation       Reconciliation    
Net income (loss) as reported   $ 3,350         $ 20,515         $ (721 )       $ 5,630      
Income tax expense     3,766           6,307           3,939           1,257      
Other, net     (448 )         159           (6,065 )         (1,070 )    
Interest expense     12,042           13,940           24,409           28,126      
Depreciation and amortization     24,650           19,192           48,899           43,932      
EBITDA     43,360           60,113           70,461           77,875      
EBITDA reconciling items from below     809           3,022           1,090           23,802      
Adjusted EBITDA   $ 44,169         $ 63,135         $ 71,551         $ 101,677      
                                 
Reconciling Items   Three Months Ended
April 30, 2026
  Three Months Ended
April 30, 2025
  Six Months Ended
April 30, 2026
  Six Months Ended
April 30, 2025
    Income
Statement
  Reconciling
Items
  Income
Statement
  Reconciling
Items
  Income
Statement
  Reconciling
Items
  Income
Statement
  Reconciling
Items
Net sales   $ 462,367     $ -     $ 452,478     $ -     $ 871,456     $ -     $ 852,522     $ -  
Cost of sales     344,575       (121 ) (1 )   321,096       (976 ) (1 )   655,137       (528 ) (1 )   628,824       (9,983 )
Selling, general and administrative     74,432       (688 ) (1),(3)   70,333       (1,110 ) (1),(3)   145,858       (562 ) (1),(3)   136,983       (4,979 )
Restructuring charges     -       -       936       (936 ) (4 )   -       -   (5 )   8,840       (8,840 )
EBITDA     43,360       809       60,113       3,022       70,461       1,090       77,875       23,802  
Depreciation and amortization     24,650       (9,776 ) (5 )   19,192       (6,454 ) (5 )   48,899       (19,533 ) (7 )   43,932       (17,104 )
Operating income     18,710       10,585       40,921       9,476       21,562       20,623       33,943       40,906  
Interest expense     (12,042 )     -       (13,940 )     -       (24,409 )     -       (28,126 )     -  
Other, net     448       (158 ) (6 )   (159 )     1,003   (6 )   6,065       (5,230 ) (6 )   1,070       831  
Income before income taxes     7,116       10,427       26,822       10,479       3,218       15,393       6,887       41,737  
Income tax expense     (3,766 )     (2,514 ) (7 )   (6,307 )     (1,882 ) (7 )   (3,939 )     (3,679 ) (7 )   (1,257 )     (9,293 )
Net income (loss)   $ 3,350     $ 7,913     $ 20,515     $ 8,597     $ (721 )   $ 11,714     $ 5,630     $ 32,444  
                                 
Diluted earnings per share   $ 0.07         $ 0.44         $ (0.02 )       $ 0.12      
                                 

(1) Expense related to plant closure/relocation.
(2) Amortization of step-up for purchase price adjustments on inventory.
(3) Transaction, advisory fees, reorganization costs and product recall expenses.
(4) Restructuring charges related to severance and disposal of software.
(5) Amortization expense related to intangible assets.
(6) Foreign currency transaction (gains) losses.
(7) Tax impact of net income reconciling items.

 
QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
 

This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

    Hardware Solutions   Extruded Solutions   Custom Solutions   Unallocated
Corp & Other
  Total
Three months ended April 30, 2026                    
Net sales   $ 203,019     $ 164,949     $ 103,913     $ (9,514 )   $ 462,367  
Cost of sales     162,392       112,881       79,017       (9,715 )     344,575  
Gross Margin     40,627       52,068       24,896       201       117,792  
Gross Margin %     20.0 %     31.6 %     24.0 %         25.5 %
Selling, general and administrative (1)     35,763       21,664       13,889       3,116       74,432  
Depreciation and amortization     11,693       7,341       5,404       212       24,650  
Operating (loss) income     (6,829 )     23,063       5,603       (3,127 )     18,710  
Depreciation and amortization     11,693       7,341       5,404       212       24,650  
EBITDA     4,864       30,404       11,007       (2,915 )     43,360  
Expense related to plant relocation (Cost of sales)     121       -       -       -       121  
Expense related to plant relocation (SG&A)     134       -       -       -       134  
Reorganization costs     75       -       1       478       554  
Adjusted EBITDA   $ 5,194     $ 30,404     $ 11,008     $ (2,437 )   $ 44,169  
Adjusted EBITDA Margin %     2.6 %     18.4 %     10.6 %         9.6 %
                     
Three months ended April 30, 2025                    
Net sales   $ 202,935     $ 163,967     $ 97,507     $ (11,931 )   $ 452,478  
Cost of sales     145,533       111,637       73,702       (9,776 )     321,096  
Gross Margin     57,402       52,330       23,805       (2,155 )     131,382  
Gross Margin %     28.3 %     31.9 %     24.4 %         29.0 %
Selling, general and administrative (1)     32,259       21,673       10,850       5,551       70,333  
Restructuring charges     896       -       -       40       936  
Depreciation and amortization     10,361       7,437       5,437       (4,043 )     19,192  
Operating income (loss)     13,886       23,220       7,518       (3,703 )     40,921  
Depreciation and amortization     10,361       7,437       5,437       (4,043 )     19,192  
EBITDA     24,247       30,657       12,955       (7,746 )     60,113  
Expense related to plant relocation (Cost of sales)     976       -       -       -       976  
Expense related to plant relocation (SG&A)     246       -       -       -       246  
Transaction, advisory fees, reorganization costs, and product recall expenses     593       19       -       252       864  
Restructuring charges     896       -       -       40       936  
Adjusted EBITDA   $ 26,958     $ 30,676     $ 12,955     $ (7,454 )   $ 63,135  
Adjusted EBITDA Margin %     13.3 %     18.7 %     13.3 %         14.0 %
                     
Six months ended April 30, 2026                    
Net sales   $ 392,131     $ 304,749     $ 193,055     $ (18,479 )   $ 871,456  
Cost of sales     313,116       210,590       150,441       (19,010 )     655,137  
Gross Margin     79,015       94,159       42,614       531       216,319  
Gross Margin %     20.2 %     30.9 %     22.1 %         24.8 %
Selling, general and administrative (1)     69,943       42,805       27,039       6,071       145,858  
Depreciation and amortization     23,240       14,680       10,626       353       48,899  
Operating (loss) income     (14,168 )     36,674       4,949       (5,893 )     21,562  
Depreciation and amortization     23,240       14,680       10,626       353       48,899  
EBITDA     9,072       51,354       15,575       (5,540 )     70,461  
Expense related to plant relocation (Cost of sales)     528       -       -       -       528  
Credit related to plant relocation (SG&A)     (8 )     -       -       -       (8 )
Reorganization costs     146       -       1       423       570  
Adjusted EBITDA   $ 9,738     $ 51,354     $ 15,576     $ (5,117 )   $ 71,551  
Adjusted EBITDA Margin %     2.5 %     16.9 %     8.1 %         8.2 %
                     
Six months ended April 30, 2025                    
Net sales   $ 387,675     $ 303,597     $ 182,545     $ (21,295 )   $ 852,522  
Cost of sales     296,318       209,317       142,000       (18,811 )     628,824  
Gross Margin     91,357       94,280       40,545       (2,484 )     223,698  
Gross Margin %     23.6 %     31.1 %     22.2 %         26.2 %
Selling, general and administrative (1)     65,616       40,181       22,448       8,738       136,983  
Restructuring charges     7,015       -       -       1,825       8,840  
Depreciation and amortization     21,831       15,077       10,977       (3,953 )     43,932  
Operating (loss) income     (3,105 )     39,022       7,120       (9,094 )     33,943  
Depreciation and amortization     21,831       15,077       10,977       (3,953 )     43,932  
EBITDA     18,726       54,099       18,097       (13,047 )     77,875  
Expense related to plant closure (Cost of sales)     976       -       -       -       976  
Gain related to plant closure (SG&A)     247       -       -       -       247  
Amortization of step-up for purchase price adjustments on inventory and accounts receivable     7,509       352       1,146       -       9,007  
Transaction and advisory fees     683       176       -       3,873       4,732  
Restructuring charges     7,015       -       -       1,825       8,840  
Adjusted EBITDA   $ 35,156     $ 54,627     $ 19,243     $ (7,349 )   $ 101,677  
Adjusted EBITDA Margin %     9.1 %     18.0 %     10.5 %         11.9 %
                     

(1) Includes stock-based compensation expense for the three and six months ended April 30, 2026, respectively of $1.5 million and $4.6 million and $0.6 million and $1.8 million for the comparable prior year periods.

 
QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA RECONCILIATION
(In thousands)
(Unaudited)
 

This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated June 5, 2025 for the three and six months ended April 30, 2025, to the current presentation.

 
    NA Fenestration   EU Fenestration   NA Cabinet Components   Tyman   Unallocated
Corp & Other
  Total
Three months ended April 30, 2025                        
Net sales   $ 151,026     $ 61,257     $ 51,237     $ 190,107     $ (1,149 )   $ 452,478  
Cost of sales     113,760       39,001       42,405       126,743       (813 )     321,096  
Gross Margin     37,266       22,256       8,832       63,364       (336 )     131,382  
Gross Margin %     24.7 %     36.3 %     17.2 %     33.3 %         29.0 %
Selling, general and administrative     15,938       9,038       5,725       37,271       2,361       70,333  
Restructuring charges     -       -       -       936       -       936  
Depreciation and amortization     4,667       2,659       3,015       8,775       76       19,192  
Operating income (loss)     16,661       10,559       92       16,382       (2,773 )     40,921  
Depreciation and amortization     4,667       2,659       3,015       8,775       76       19,192  
EBITDA     21,328       13,218       3,107       25,157       (2,697 )     60,113  
Expense related to plant relocation (Cost of sales)     976       -       -       -       -       976  
Expense related to plant relocation (SG&A)     246       -       -       -       -       246  
Transaction, advisory fees, and reorganization costs     -       -       -       675       189       864  
Restructuring charges related to severance and disposal of software     -       -       -       936       -       936  
Adjusted EBITDA   $ 22,550     $ 13,218     $ 3,107     $ 26,768     $ (2,508 )   $ 63,135  
Adjusted EBITDA Margin %     14.9 %     21.6 %     6.1 %     14.1 %         14.0 %
                         
    Hardware Solutions(1)   Extruded Solutions(2)   Custom Solutions(3)   Tyman   Unallocated
Corp & Other
  Total
Three months ended April 30, 2025                        
Net sales   $ 202,935     $ 163,967     $ 97,507     $ -     $ (11,931 )   $ 452,478  
Cost of sales     145,533       111,637       73,702       -       (9,776 )     321,096  
Gross Margin     57,402       52,330       23,805       -       (2,155 )     131,382  
Gross Margin %     28.3 %     31.9 %     24.4 %             29.0 %
Selling, general and administrative     32,259       21,673       10,850           5,551       70,333  
Restructuring charges     896       -       -       -       40       936  
Depreciation and amortization     10,361       7,437       5,437       -       (4,043 )     19,192  
Operating (loss) income     13,886       23,220       7,518       -       (3,703 )     40,921  
Depreciation and amortization     10,361       7,437       5,437       -       (4,043 )     19,192  
EBITDA     24,247       30,657       12,955       -       (7,746 )     60,113  
Expense related to plant relocation (Cost of sales)     976       -       -       -       -       976  
Expense related to plant relocation (SG&A)     246       -       -       -       -       246  
Transaction, advisory fees, and reorganization costs     593       19       -       -       252       864  
Restructuring charges related to severance and disposal of software     896       -       -       -       40       936  
Adjusted EBITDA   $ 26,958     $ 30,676     $ 12,955     $ -     $ (7,454 )   $ 63,135  
Adjusted EBITDA Margin %     13.3 %     18.7 %     13.3 %             14.0 %
                         
    NA Fenestration   EU Fenestration   NA Cabinet Components   Tyman   Unallocated
Corp & Other
  Total
Six months ended April 30, 2025                        
Net sales   $ 285,359     $ 109,728     $ 95,047     $ 365,783     $ (3,395 )   $ 852,522  
Cost of sales     220,327       69,638       81,821       259,539       (2,501 )     628,824  
Gross Margin     65,032       40,090       13,226       106,244       (894 )     223,698  
Gross Margin %     22.8 %     36.5 %     13.9 %     29.0 %         26.2 %
Selling, general and administrative     32,071       16,959       10,992       71,649       5,312       136,983  
Restructuring charges     -       -       -       8,840       -       8,840  
Depreciation and amortization     9,446       5,269       6,024       23,038       155       43,932  
Asset impairment charges     -       -       -       -       -       -  
Operating income (loss)     23,515       17,862       (3,790 )     2,717       (6,361 )     33,943  
Depreciation and amortization     9,446       5,269       6,024       23,038       155       43,932  
EBITDA     32,961       23,131       2,234       25,755       (6,206 )     77,875  
Expense related to plant relocation (Cost of sales)     976       -       -       -       -       976  
Expense related to plant relocation (SG&A)     247       -       -       -       -       247  
Amortization of step-up for purchase price adjustments on inventory and accounts receivable     -       -       -       9,007       -       9,007  
Transaction, advisory fees, and reorganization costs     -       -       -       2,142       2,590       4,732  
Restructuring charges related to severance and disposal of software     -       -       -       8,840       -       8,840  
Adjusted EBITDA   $ 34,184     $ 23,131     $ 2,234     $ 45,744     $ (3,616 )   $ 101,677  
Adjusted EBITDA Margin %     12.0 %     21.1 %     2.4 %     12.5 %         11.9 %
                         
    Hardware Solutions(1)   Extruded Solutions(2)   Custom Solutions(3)   Tyman   Unallocated
Corp & Other
  Total
Six months ended April 30, 2025                        
Net sales   $ 387,675     $ 303,597     $ 182,545     $ -     $ (21,295 )   $ 852,522  
Cost of sales     296,318       209,317       142,000       -       (18,811 )     628,824  
Gross Margin     91,357       94,280       40,545       -       (2,484 )     223,698  
Gross Margin %     23.6 %     31.1 %     22.2 %             26.2 %
Selling, general and administrative     65,616       40,181       22,448       -       8,738       136,983  
Restructuring charges     7,015       -       -           1,825       8,840  
Depreciation and amortization     21,831       15,077       10,977       -       (3,953 )     43,932  
Operating income (loss)     (3,105 )     39,022       7,120       -       (9,094 )     33,943  
Depreciation and amortization     21,831       15,077       10,977       -       (3,953 )     43,932  
EBITDA     18,726       54,099       18,097       -       (13,047 )     77,875  
Expense related to plant relocation (Cost of sales)     976       -       -       -       -       976  
Expense related to plant relocation (SG&A)     247       -       -       -       -       247  
Amortization of step-up for purchase price adjustments on inventory and accounts receivable     7,509       352       1,146       -       -       9,007  
Transaction and advisory fees     683       176       -       -       3,873       4,732  
Restructuring charges     7,015       -       -           1,825       8,840  
Adjusted EBITDA   $ 35,156     $ 54,627     $ 19,243     $ -     $ (7,349 )   $ 101,677  
Adjusted EBITDA Margin %     9.1 %     18.0 %     10.5 %             11.9 %
                         

(1) The Hardware Solutions segment contains a portion of the previously reported NA Fenestration segment.
(2) The Extruded Solutions segment contains a portion of the previously reported NA Fenestration and the EU Fenestration segments.
(3) The Custom Solutions segment contains a portion of the previously reported NA Fenestration and the NA Cabinet Components segments.

       
QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
       
  Three Months Ended April 30,
  Six Months Ended April 30,
    2026       2025       2026       2025  
               
Hardware Solutions:(1)              
Window and door hardware $ 109,377     $ 104,887     $ 234,078     $ 227,240  
Screens   91,482       95,860       154,081       156,414  
Other   2,160       2,188       3,972       4,021  
  $ 203,019     $ 202,935     $ 392,131     $ 387,675  
Extruded Solutions:(2)              
Window profiles $ 72,542     $ 70,009     $ 130,897     $ 129,854  
Seals and gaskets   19,530       19,401       37,164       37,442  
Spacers   52,526       50,671       100,128       93,532  
Solar   5,312       7,062       9,917       12,585  
Flashing Tape   3,228       1,599       4,746       3,713  
Window and door hardware   8,470       11,177       15,982       20,635  
Other   3,341       4,048       5,915       5,836  
  $ 164,949     $ 163,967     $ 304,749     $ 303,597  
Custom Solutions:(3)              
Wood solutions $ 56,906     $ 51,237     $ 103,560     $ 95,047  
Access solutions   26,455       23,880       49,501       46,788  
Mixing solutions   20,552       22,390       39,994       40,710  
  $ 103,913     $ 97,507     $ 193,055     $ 182,545  
               
Unallocated Corporate & Other:              
Eliminations $ (9,514 )   $ (11,931 )   $ (18,479 )   $ (21,295 )
  $ (9,514 )   $ (11,931 )   $ (18,479 )   $ (21,295 )
               
Net Sales $ 462,367     $ 452,478     $ 871,456     $ 852,522  
               

(1) Reflects an increase of $4.4 million and $6.7 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2026, respectively.
(2) Reflects an increase of $5.9 million and $8.6 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2026, respectively.
(3) Reflects an increase of $0.5 million and $0.3 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2026, respectively.